Form 4: GoodRx Holdings Executive Scott Wagner Reports Stock Transactions

GoodRx Holdings' Interim CEO, Scott Wagner, reports the acquisition and disposal of Class A common stock and restricted stock units.

Summary

• Scott Wagner, Interim CEO of GoodRx Holdings, reported transactions involving the company's Class A common stock on November 8, 2024.
• Wagner acquired 70,592 shares of Class A common stock through the vesting of restricted stock units.
• He also disposed of 35,777 shares of Class A common stock to cover tax obligations at a price of $5.04 per share.
• Following these transactions, Wagner directly owns 254,294 shares of Class A common stock and indirectly owns 182,900 shares through the Wagner Family Trust.
• The restricted stock units vest in monthly installments over eight months starting May 8, 2024.

Sentiment

Score: 6

Explanation: The document reflects routine insider transactions, which are neither particularly positive nor negative. The vesting of stock units is a positive incentive, while the sale for tax obligations is neutral.

Positives

• The vesting of restricted stock units indicates a positive incentive for the executive.
• The executive's continued employment is tied to the vesting schedule, aligning his interests with the company's performance.

Negatives

• The sale of shares to cover tax obligations could be seen as a slight negative, although it is a common practice.

Risks

• The sale of shares by an executive could be interpreted negatively by the market, although this is a common practice for tax obligations.
• Changes in executive ownership can sometimes lead to uncertainty among investors.

Management Comments

• Scott Wagner is the Interim Chief Executive Officer of GoodRx Holdings.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into executive stock ownership and compensation.

Comparison to Industry Standards

• Executive stock transactions are a standard practice in publicly traded companies, and the reporting of these transactions via SEC Form 4 is a regulatory requirement.
• The vesting schedule of the restricted stock units is typical for executive compensation packages, often designed to align executive interests with long-term company performance.
• The sale of shares to cover tax obligations is a common practice among executives who receive equity compensation.

Stakeholder Impact

• The transactions may have a minor impact on shareholder sentiment, but are generally considered routine.

Key Dates

Keywords

GoodRx Holdings, GDRX, Scott Wagner, Class A Common Stock, Restricted Stock Units, Insider Trading, SEC Form 4, Executive Compensation, Stock Transactions